MacroGenics, Inc. - Common Stock — 재무제표 (NASDAQ:MGNX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 378.74 M335.25 M280.47 M298.42 M261.65 M256.85 M 총 부채 82.86 M95.63 M138.46 M145.81 M145.6 M201.25 M 자본금 총액 295.88 M239.62 M142.01 M152.61 M116.06 M55.59 M 총 부채 및 주주자본 378.74 M335.25 M280.47 M298.42 M261.65 M256.85 M 총부채 —————— 순부채 ——————

뉴스

Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance

MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates

CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates

Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates

Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know

SNY's Tzield Gets FDA Nod for Kids, Sarclisa SC BLA Faces Delay

MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX)

MacroGenics, 2026년 전략적 재도약 목표 제시

MacroGenics at The Citizens Life Sciences Conference: Strategic Reemergence in 2026

매크로제닉스, Leerink 헬스케어 컨퍼런스 참가

MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus

스티펠, MacroGenics에 ’보유’ 등급 유지, 목표가 4달러